Mycobacterial and other serious infections in patients receiving anti-tumor necrosis factor and other newly approved biologic therapies: Case finding through the emerging infections network

Kevin L. Winthrop, S. Yamashita, S. E. Beekmann, P. M. Polgreen

Research output: Contribution to journalArticlepeer-review

167 Scopus citations

Fingerprint

Dive into the research topics of 'Mycobacterial and other serious infections in patients receiving anti-tumor necrosis factor and other newly approved biologic therapies: Case finding through the emerging infections network'. Together they form a unique fingerprint.

Medicine & Life Sciences